Cancidas Injection, Powder, Lyophilized, For Solution
Product Images NDC 0006-3822

4 FDA label images from Merck Sharp & Dohme Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cancidas (NDC 0006-3822). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Merck Sharp & Dohme Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Cancidas 01)

Formula (Cancidas 01)
An illustration showing the formula to calculate Body Surface Area (BSA). The formula is BSA (m²) equals the square root of the height in centimeters multiplied by weight in kilograms divided by 3600.*
FDA Label Image

Chemical Structure (Cancidas 02)

Chemical Structure (Cancidas 02)
Chemical structure of caspofungin acetate, the active ingredient in CANCIDAS injection, powder, lyophilized, for solution by Merck Sharp & Dohme LLC.*
FDA Label Image

Principal Display Panel (50 mg Vial Carton)

Principal Display Panel (50 mg Vial Carton)
Packaging label for CANCIDAS 50 mg injection, lyophilized powder for solution, containing caspofungin acetate. The label indicates it is for intravenous use only, manufactured by Merck Sharp & Dohme LLC. The label includes preparation instructions, storage conditions, and a barcode. The product is a single-dose vial.*
FDA Label Image

Principal Display Panel (70 mg Vial Carton)

Principal Display Panel (70 mg Vial Carton)
Packaging label for CANCIDAS (caspofungin acetate) Injection 70 mg, a lyophilized powder for intravenous solution by Merck Sharp & Dohme LLC. The label includes dosage preparation instructions, storage conditions at 2 to 8°C, and warnings against the use of diluents containing dextrose. It indicates a single-dose vial with 7 mg/mL concentration after reconstitution.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.